Home / Inspections / 1266883

FDA Inspection 1266883 — Merck Sharp & Dohme BV

Merck Sharp & Dohme BV — FEI 3002807658

The FDA completed an inspection of Merck Sharp & Dohme BV on October 17, 2024 in Haarlem. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 17, 2024
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Haarlem (Netherlands)

Additional Details

Mutual Recognition Agreement (MRA)

Facility

Other inspections at this facility

  • 1077038 (NAI Thu Dec 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1023619 (VAI Fri Jul 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 903950 (NAI Thu Nov 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 811783 (NAI Thu Nov 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 637962 (NAI Thu Dec 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources